ARARIS
LIVE

Serial Number

79418078

Owner

Araris Biotech AG

Attorney

Catherine F Hoffman

Filing Date

Jul 31, 2024

Add to watchlist:

No watchlists yet
View on USPTO

ARARIS Trademark

Serial Number: 79418078 • Registration: 8081813

ARARIS is a trademark filed by Araris Biotech AG on July 31, 2024. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Araris Biotech AG (4 trademarks)

Riedhofstrasse 11

Entity Type: 98

Trademark Details

Filing Date

July 31, 2024

Registration Date

December 30, 2025

Published for Opposition

November 11, 2025

Goods & Services

Pharmaceutical products namely, pharmaceutical preparations for the treatment of oncology, immunology, inflammation, infectious diseases, cardiovascular and metabolism diseases; medical preparations for the treatment of oncology, immunology, inflammation, infectious diseases, cardiovascular and metabolism diseases; pharmaceuticals and medical preparations in the field of cancer therapy; biopharmaceuticals and medical preparations in the field of active antibody conjugates for the treatment of oncology, immunology, inflammation, infectious diseases, cardiovascular and metabolism diseases; chemical, biological, molecular genetic and biochemical and biopharmaceutical products for medical, pharmaceutical use, namely synthetic peptides for the treatment of oncology, immunology, inflammation, infectious diseases, cardiovascular and metabolism diseases, diagnostic preparations for medical or veterinary purposes in the nature of peptide derivatives being substates, proteins arrays for medical diagnosis purposes, antibodies for medical purposes, active antibody conjugates being antibodies for medical purposes, antibody fragments being antibodies for medical purposes, antibody derivatives being antibodies for medical purposes, nucleic acids for medical or veterinary purposes, DNA being diagnostic preparations for in vitro testing for medical use, viral vector vaccines; pharmaceutical products and substances being pharmaceutical preparations for the treatment of diseases and preparations for medical treatments of oncology, immunology, inflammation, infectious diseases, cardiovascular and metabolism diseases

Scientific and technological services as well as research work and design services relating thereto, namely, scientific research services provided by scientists dedicated to the chemical and technological study of biological molecules; scientific, medical, biological, molecular genetic, chemical, pharmaceutical and technological research, in the field of biochemistry or pharmacy; Scientific laboratory services of a biochemical or pharmaceutical laboratory ; industrial analysis and research services in the field of pharmaceutical science ; development and research experimentation of medicines; Medical and scientific research, namely conducting preclinical and clinical trials for others; laboratory services for the benefit of third parties, namely,Medical laboratory services; scientific research advisory services in the biochemical, biological and molecular genetic fields; scientific research advice for the pharmaceutical industry sector; scientific research analysis services for medical and pharmaceutical research services in connection with the treatment of individuals; provision of scientific research information and results.

Providing business information with respect to business contacts for research projects.

Chemical, biochemical, biological and molecular genetic products intended for laboratory analysis, industry and science namely, chemicals for use in industry and science, biochemical preparations for scientific purposes, Biological preparations for use in industry and science, assays and reagents for use in genetic research; bioactive reagents and compounds namely, diagnostic reagents and preparations, except for medical or veterinary use; peptide substrates for scientific purposes; peptide derivatives in the nature of peptide substrates for scientific purposes, proteins in raw material form for scientific and medical research, glycans being chemicals for use in industry and science, nucleotides for scientific and medical research use, lipids used in the manufacture of cosmetics, beverages, food products and food supplements, monoclonal antiobodies for scientific purposes, antibody-active principle conjugates in the nature of antibody reagents used for the detection of antigens in cells and tissue, other than for medical or vetinary purposes, antibody fragments in the nature of antibody reagents used for the detection of antigens in cells and tissue, other than for medical or veterinary purposes, antibody derivatives in the nature of antibody reagents used for the detection of antigens in cells and tissue, other than for medical or veterinary purposes, nucleic acids other than for medical or veterinary purposes, DNA being diagnostic preparations for in vitro testing for scientific use, viral vectors for research purposes; chemical, biochemical, biological, biotechnological and molecular genetic preparations in the nature of assays and reagents for use in genetic research for industrial and scientific use; chemical, biological, biotechnological and molecular genetic preparations, namely polypeptides for in vitro research use and industrial proteins for reagent development or production for industrial and scientific applications; biological preparations, namely polypeptides for in vetro research use, peptide derivatives in the nature of peptide substrates for scientific purposes and industrial proteins for laboratories and analysis for industrial and scientific applications; chemical and biochemical substances for use in the manufacture of pharmaceuticals.

Filing History

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 30, 2026 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Dec 30, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Dec 30, 2025 R.PR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 11, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 11, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 11, 2025 REAP
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 11, 2025 NPUB
PUBLISHED FOR OPPOSITION
Nov 11, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 5, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 15, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Oct 14, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Oct 14, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Oct 14, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Oct 14, 2025 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 27, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 27, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 27, 2025 TROA
REFUSAL PROCESSED BY IB
May 4, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 15, 2025 RFCS
REFUSAL PROCESSED BY MPU
Apr 15, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 8, 2025 RFCR
NON-FINAL ACTION WRITTEN
Mar 7, 2025 CNRT
ASSIGNED TO EXAMINER
Mar 1, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Feb 28, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 28, 2025 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 27, 2025 REPR